A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...
Eli Lilly and Co. shares are trading higher on Tuesday as the company is reporting new data on its treatment for ulcerative ...
Targeted dietary therapies can induce remission in 50%-80% of IBD patients; discover which protocols — EEN, CDED, and whole ...
Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral ...
A new combination drug therapy could help people with inflammatory bowel disease (IBD) for whom other medicines have stopped ...
Scientists have uncovered an unexpected mechanism by which the gut’s immune system maintains balance, challenging ...
A closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD ...
Hosted on MSN
Living well with inflammatory bowel disease
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, affects millions and can be life-altering ...
The occurrence of microscopic colitis in Sweden has risen steadily over the past decades, according to a new study from ...
In this study roundup, Medical News Today compiles the latest evidence on the benefits of Vitamin D, focusing on the key ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results